Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea

References

• Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991;324:1043–1048.
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325(16):1127–1131.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345(8964):1525–1528.
   PubMed Web of Science ®Google Scholar
• Samloff IM. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology. 1982;82(1):26–33.
   PubMed Web of Science ®Google Scholar
• Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83(1 Pt 2):204–209.
   PubMed Web of Science ®Google Scholar
• Mukoubayashi C, Yanaoka K, Ohata H, et al. Serum pepsinogen and gastric cancer screening. Intern Med. 2007;46(6):261–266.
   PubMed Web of Science ®Google Scholar
• Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogen as a screening test of extensive chronic gastritis. Gastroenterol Jpn. 1987;22(2):133–141.
   PubMedGoogle Scholar
• Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res. 1989;80(2):111–114.
   PubMedGoogle Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
   PubMed Web of Science ®Google Scholar
• Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
   PubMedGoogle Scholar
• Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–429.
   PubMed Web of Science ®Google Scholar
• Lee JH, Choi KD, Jung HY, et al. Seroprevalence of Helicobacter pylori in Korea: a multicenter, nationwide study conducted in 2015 and 2016. Helicobacter. 2018;23(2):e12463.
   PubMed Web of Science ®Google Scholar
• Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009;24(10):1587–1600.
   PubMed Web of Science ®Google Scholar
• Hojo M, Miwa H, Ohkusa T, et al. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16(11):1923–1932.
   PubMed Web of Science ®Google Scholar
• Ohkusa T, Miwa H, Nomura T, et al. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Aliment Pharmacol Ther. 2004;20(s1):25–32.
   PubMed Web of Science ®Google Scholar
• Osumi H, Fujisaki J, Suganuma T, et al. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication. PLoS One. 2017;12(8):e0183980.
   PubMed Web of Science ®Google Scholar
• Cho JH, Chang YW, Jang JY, et al. Close observation of gastric mucosal pattern by standard endoscopy can predict Helicobacter pylori infection status. J Gastroenterol Hepatol. 2013;28(2):279–284.
   PubMed Web of Science ®Google Scholar
• Cho JH, Jeon SR, Kim HG, et al. Factors for improving the diagnostic efficiency of the rapid urease test from the gastric corpus. Scand J Gastroenterol. 2017;52(12):1320–1325.
   PubMed Web of Science ®Google Scholar
• Woo HY, Park DI, Park H, et al. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter. 2009;14(1):22–28.
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–1181.
   PubMed Web of Science ®Google Scholar
• Kodoi A, Yoshihara M, Sumii K, et al. Serum pepsinogen in screening for gastric cancer. J Gastroenterol. 1995;30(4):452–460.
   PubMed Web of Science ®Google Scholar
• Cho JH, Jeon SR, Kim HG, et al. Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutations that causes clarithromycin resistance in Korean patients. J Gastroenterol Hepatol. 2019;34(4):700–706.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Mégraud F, O Morain CA, et al. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–1095.
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367.
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789.
   PubMed Web of Science ®Google Scholar
• Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16(5):382–388.
   PubMed Web of Science ®Google Scholar
• Asaka M, Mabe K, Matsushima R, et al. Helicobacter pylori eradication to eliminate gastric cancer: the Japanese strategy. Gastroenterol Clin N Am. 2015;44(3):639–648.
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735–6740.
   PubMed Web of Science ®Google Scholar
• Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187–194.
   PubMed Web of Science ®Google Scholar
• Take S, Mizuno M, Ishiki K, et al. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol. 2007;42(S17):21–27.
   PubMed Web of Science ®Google Scholar
• Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–624.
   PubMed Web of Science ®Google Scholar
• Graham DY. Roadmap for elimination of gastric cancer in Korea. Korean J Intern Med. 2015;30(2):133–139.
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Yamaki G, Miki K, et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen. 2004;11(3):141–147.
   PubMed Web of Science ®Google Scholar
• Mizuno S, Kobayashi M, Tomita S, et al. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer. 2009;12(3):158–163.
   PubMed Web of Science ®Google Scholar
• Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999;44(5):693–697.
   PubMed Web of Science ®Google Scholar
• Kang JM, Kim N, Yoo JY, et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter. 2008;13(2):146–156.
   PubMed Web of Science ®Google Scholar
• Cho JH, Jeon SR, Kim HG, et al. The serum pepsinogen levels for risk assessment of gastric neoplasms: new proposal from a case-control study in Korea. Medicine. 2017;96(29):e7603.
   PubMed Web of Science ®Google Scholar
• Iguchi M, Kato J, Yoshida T, et al. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection. Int J Cancer. 2016;139(5):1150–1156.
   PubMed Web of Science ®Google Scholar
• Kwon Y, Jeon S, Nam S, et al. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. Aliment Pharmacol Ther. 2017;46(8):758–767.
   PubMed Web of Science ®Google Scholar
• Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer. 2009;125(11):2697–2703.
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997;113(1):15–24.
   PubMed Web of Science ®Google Scholar
• Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117(1):60–69.
   PubMed Web of Science ®Google Scholar
• Iijima K, Sekine H, Koike T, et al. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther. 2004;19(11):1181–1188.
   PubMed Web of Science ®Google Scholar
• Iijima K, Sekine H, Koike T, et al. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol. 2005;40(10):938–944.
   PubMed Web of Science ®Google Scholar
• Iijima K, Koike T, Abe Y, et al. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after Helicobacter pylori eradication. J Gastroenterol. 2009;44(8):819–825.
   PubMed Web of Science ®Google Scholar
• Kato M, Ota H, Okuda M, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 revised edition. Helicobacter. 2019;24:e12597.
   PubMed Web of Science ®Google Scholar
• Leja M, Park JY, Murillo R, et al. Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study. BMJ Open. 2017;7(8):e016999.
   PubMed Web of Science ®Google Scholar
• Kim EH, Kang H, Park CH, et al. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis. Dig Liver Dis. 2015;47(8):663–668.
   PubMedGoogle Scholar